Researchers offer evidence of the importance of epithelial-to-mesenchymal transition (EMT) in the progression of chronic kidney disease.
Using TIBCO Spotfire® visualization tools, PerkinElmer demonstrates this analytical versatile software in the study of infectious diseases.
Using a suite of PerkinElmer's analytical imaging instruments, Dementias Platform United Kingdom (DPUK) is taking a whole-body approach to early detection, better treatment, and prevention of neurodegenerative conditions including Parkinson’s Disease, Motor Neurone Diseases, Multiple Sclerosis, Huntington’s Disease, Creutzfeldt–Jakob Disease, and Alzheimer’s Disease.
Scientists morph stem cells into mini-brains to prove that the Zika virus causes massive brain cell death in fetuses.
Groundbreaking research using PerkinElmer's Vectra multispectral imaging platform may lead to new immunotherapy treatments for cancer.
Using high content cellular imaging to engineer new drug therapies to combat human diseases.
High-tech imaging systems help identify new drugs to fight multiple sclerosis.
Spanish researchers hope to revolutionize drug repositioning with new online tool NFFinder
Breakthrough research uses bacteria to target and kill cancer
In Mice and Men: Gene Therapy Prevents Muscular Dystrophy
Seeing Elements Transform At Atomic Scale Unveils A Big Surprise: A Potential New Cancer Therapy
Yale University research shows reversal of memory loss from Alzheimer's disease.
Chinese researchers develop a "magic bullet" against Parkinson's disease with the help of PerkinElmer.
PerkinElmer’s Solaris™ open-air fluorescence imaging system displays tumors in real time on large monitors under normal lighting conditions.
Researchers are searching for ways to restore neural function after traumatic brain injuries. Research using human neural stem cells (hNSCs) is showing promise.
By studying changes in the shape of cells and organelles in response to cancer drugs, researchers hope to pave the way for more effective breast cancer treatments.